InvestorsHub Logo
Followers 4
Posts 549
Boards Moderated 0
Alias Born 04/04/2013

Re: erostratus post# 5115

Friday, 10/04/2013 11:41:07 AM

Friday, October 04, 2013 11:41:07 AM

Post# of 48316
I will never bash ONCS on the fundamental level. They have an excellent company with a more than promising future. The sp, this early in the game, is something they cant control. It has nothing to do with how theyre running the co. Look at INO $2+.... I think ONCS shows a lot more potential and is ahead in the pre clinical and clinical trials.